Novo's Cagrisema Delivers Superior Weight Loss Versus Tirzepatide In Reimagine 5 Trial

Cagrisema 1.0 Mg/1.0 Mg Achieves 12.4% Weight Loss Vs 9.1% Tirzepatide At Week 60 Cagrisema 1.0 Mg/1.0 Mg Confirms Non-Inferior Hba(1c) Reduction Of 1.71% Vs 1.67% Tirzepatide Cagrisema Shows Greater Improvements Than Placebo In Multiple Supportive Endpoints